Evidence map›Paper›PMID 24312115›Full record

ArticleFrontiers in genetics2013

Increasing the power of association studies with affected families, unrelated cases and controls.

William C L Stewart, Jane Cerise

Abstract read
In one paragraph

Article in Frontiers in genetics, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

William C L StewartBattelle Center for Mathematical Medicine at The Research Institute, Nationwide Children's Hospital Columbus, OH, USA ; Department of Statistics and Pediatrics, Ohio State University Columbus, OH, USA.
Jane Cerise

Funding

RESOLVING HETEROGENEITY IN EPILEPSY WITH GENETIC MARKERSR01NS027941 · NINDS · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI GREENBERG, DAVID A. · 1990 to 2010
$9.0M
Biomarkers for Arsenic Toxicity: Genetics, Epigenetics and FolateR01ES017875 · NIEHS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI GAMBLE, MARY · 2010 to 2013
$1.9M
Genetic Analysis: Psychiatric and Other Complex DiseasesT32MH065213 · NIMH · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI WEISSMAN, MYRNA M · 2002 to 2011
$1.7M
PSYCHIATRIC GENETICS AND FAMILY STUDIES--ROBUST METHODSR01MH048858 · NIMH · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI HODGE, SUSAN E. · 1992 to 2010
$1.5M
NIEHS NIH HHS R01 ES017875NIMH NIH HHS R01 MH048858NIMH NIH HHS T32 MH065213NINDS NIH HHS R01 NS027941
6 · The paper itself

Abstract

When studying the genetics of inherited diseases, researchers often collect data on affected families, unrelated cases, and healthy controls. However, the joint analysis of such heterogeneous data is difficult, and the simpler analysis of homogeneous subsets is often suboptimal. For example, while case-control tests of association are sensitive to allele frequency differences, the preferential transmission of risk alleles from heterozygous parents to their affected offspring is typically ignored. Similarly, the transmission disequilibrium test (TDT) fails to incorporate the difference in allele frequencies when testing for association. To boost the power of modern genetic studies, we propose POPFAM - a fast and efficient test of association that can accommodate large affected families, unrelated cases, and controls. We use simulations to assess the type I error and power of POPFAM across different genetic models, and minor allele frequencies. For comparison, we examine the power of competing methods: the trend test, a Wald test (equivalent to the TDT), and SCOUT. Our results show that POPFAM maintains the correct type I error, and that it is more powerful than the trend test or the TDT. It performs as well as, or better than the likelihood ratio test SCOUT, which was developed specifically for case-parent/case-control data. Furthermore, when applied to the human leukocyte antigen genotypes of 401 type 1 diabetic families, POPFAM confirmed the previously reported association between DRB1(*)03:01 and microvascular complications (p = 0.04). In general, we expect our proposed test to facilitate the identification of clinically important genomic regions, and to better inform the design of follow-up sequencing efforts.

Indexed as

associationcase-controldiabetesPOPFAMsequencing

Identifiers

PMID24312115
PMCPMC3836002

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.